In May 2025, the Chinese vitamin market prices continued to be weak and stable, folic acid prices were relatively firm, and other vitamin categories were weak and stable.
On 12 May, 2025, Suzhou Xiehe held a 2025 brand press conference in Shanghai, introducing the Xiehe B5 series new products.
On 11 May, 2025, Guangdong Sungen founded a subsidiary in Fukuoka.
In late April, the vitamin B6 injection of CR Double-Crane's subsidiary passed the consistency evaluation.
Project Progress of Multiple Companies:
- Tianxin Pharma's 500 t/a Vitamin A project
- Weirong Pharma's 400 kg/a Vitamin D2 crude product project
- Goto Biotech's vitamin and enzyme production and transformation project
The USD/RMB exchange rate in this Report is USD1.00=CNY7.2008 on 6 May 2025, sourced from the People's Bank of China. All the prices mentioned in this Report will include the VAT, unless otherwise specified.
Please purchase to view
Add to cart
